Using a Learning Collaborative Strategy With Office-based Practices to Increase Access and Improve Quality of Care for Patients With Opioid Use Disorders
Authors:
- Benjamin R. NordstromBNBenjamin R. Nordstrom
- Elizabeth C. SaundersESElizabeth C. Saunders
- Bethany BA McLemanBMBethany BA McLeman
- Andrea MeierAMAndrea Meier
- Haiyi XieHXHaiyi Xie
- Chantal Ma Lambert-HarrisCLChantal Ma Lambert-Harris
- Beth Msw TanzmanBTBeth Msw Tanzman
- John BrooklynJBJohn Brooklyn
- Gregory KingGKGregory King
- Nels KlosterNKNels Kloster
- Clifton Frederick LordCLClifton Frederick Lord
- William RobertsWRWilliam Roberts
- 1 March 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Addiction Medicine
- Vol. 10 (2) , 117-123
Abstract
Objectives: Rapidly escalating rates of heroin and prescription opioid use have been widely observed in rural areas across the United States. Although US Food and Drug Administration-approved medications for opioid use disorders exist, they are not routinely accessible to patients. One medication, buprenorphine, can be prescribed by waivered physicians in office-based practice settings, but practice patterns vary widely. This study explored the use of a learning collaborative method to improve the provision of buprenorphine in the state of Vermont. Methods: We initiated a learning collaborative with 4 cohorts of physician practices (28 total practices). The learning collaborative consisted of a series of 4 face-to-face and 5 teleconference sessions over 9 months. Practices collected and reported on 8 quality-improvement data measures, which included the number of patients prescribed buprenorphine, and the percent of unstable patients seen weekly. Changes from baseline to 8 months were examined using a p-chart and logistic regression methodology. Results: Physician engagement in the learning collaborative was favorable across all 4 cohorts (85.7%). On 6 of the 7 quality-improvement measures, there were improvements from baseline to 8 months. On 4 measures, these improvements were statistically significant (P < 0.001). Importantly, practice variation decreased over time on all measures. The number of patients receiving medication increased only slightly (3.4%). Conclusions: Results support the effectiveness of a learning collaborative approach to engage physicians, modestly improve patient access, and significantly reduce practice variation. The strategy is potentially generalizable to other systems and regions struggling with this important public health problem.Keywords
This publication has 24 references indexed in Scilit:
- The p-control chart: a tool for care improvementInternational Journal for Quality in Health Care, 2010
- Factors affecting willingness to provide buprenorphine treatmentJournal of Substance Abuse Treatment, 2009
- Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative StudyJournal of General Internal Medicine, 2008
- Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and BarriersJournal of General Internal Medicine, 2008
- Evidence for the impact of quality improvement collaboratives: systematic reviewBMJ, 2008
- State policy influence on the early diffusion of buprenorphine in community treatment programsSubstance Abuse Treatment, Prevention, and Policy, 2008
- Buprenorphine: The Basic Pharmacology RevisitedJournal of Addiction Medicine, 2007
- The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clustersDrug and Alcohol Dependence, 2007
- Early adoption of buprenorphine in substance abuse treatment centers: Data from the private and public sectorsJournal of Substance Abuse Treatment, 2006
- Primary Care Practice-Based Research Networks: Working at the Interface Between Research and Quality ImprovementThe Annals of Family Medicine, 2005